INOVIO PHARMACEUTI earnings per share and revenue

GBM earnings per share for the last quarter are -1.07 CHF whereas the estimation was -0.99 CHF which accounts for -8.02% surprise. Company revenue for the same period amounts to 90.59 k CHF despite the estimated figure of 120.47 k CHF. Estimated earnings per share for the next quarter are -0.97 CHF, and revenue is expected to reach 95.62 k CHF. Also watch annual changes over time to get a bigger picture of GBM earnings per share and revenue dynamics.